$MIRA 3 SEC Filings

Filed On	Filing
09 Jun 2026	Form 3: Mushak Andriy, Chief Financial Officer No securities owned
03 Oct 2025	Form 3: Mira PHARMACEUTICALS, Inc., 10% owner · Telomir Pharmaceuticals Inc Holds 3,521,127 shares of Common Stock, no par value
10 Jun 2025	Form 3: Weichselbaum Alan, Chief Financial Officer
26 Nov 2024	Form 3: Whalen Matthew Pratt, Director No securities owned
22 Mar 2024	Form 3: Shekhat Denil Nanji, Director No securities owned
22 Mar 2024	Form 3: Del Giudice Matthew Paul, Director No securities owned
22 Mar 2024	Form 3: MacPherson Edward Clouston, Director No securities owned
20 Nov 2023	Form 3: Jerman Michael Allen, Director No securities owned
03 Nov 2023	Form 3: Daly Brian Frederick, Director No securities owned
12 Oct 2023	Form 3: McNulty Brian Patrick, 10% owner Holds 10,000 shares of Common Stock
02 Aug 2023	Form 3: Cappy George, 10% owner and 1 other Holds 20,000 shares of Common Stock
02 Aug 2023	Form 3: Yanez Michelle, CFO, Secretary & Treasurer
02 Aug 2023	Form 3: Vorhoff David C, Director Holds 40,000 shares of Common Stock
02 Aug 2023	Form 3: Tuck Talhia, Director Holds 20,000 shares of Common Stock
02 Aug 2023	Form 3: Nicholoudis Christos, Director
02 Aug 2023	Form 3: McColl Hugh Iii, Director Holds 40,000 shares of Common Stock
02 Aug 2023	Form 3: Kroenig Bradley, Director Holds 50,000 shares of Common Stock
02 Aug 2023	Form 3: Kaplin Adam, Pres. & Chief Scientific Off. Holds 200,000 shares of Common Stock
02 Aug 2023	Form 3: Chapman Christopher C Jr, Director Holds 200,000 shares of Common Stock
02 Aug 2023	Form 3: Aminov Erez, Director Holds 373,500 shares of Common Stock

Comments